General Synthetic Procedures
All reagents were purchased from Sigma-Aldrich, Acros Organics, Fluka and Fisher Scientific, FluoroChem, Jena Bioscience or Alfa Aesar and used without further purification. Dry solvents (pyridine, Et 3 N, CH 2 Cl 2 , THF, MeCN) were obtained using an MBraun SPS Bench Top solvent purification system (SPS). All air/moisture sensitive reactions were carried out under inert atmosphere (argon) in oven-dried glassware. Solvents used for phosphitylation reactions and purification were also degassed by saturating the solvents with argon for 20 min. Reactions were monitored by thin layer chromatography (TLC) using Merck Kieselgel 60 F24 silica gel plates (0.22 mm thickness, aluminium backed). The compounds were visualized by UV irradiation at 254/265 nm and by staining in p-anisaldehyde or ninhydrin solution followed by gentle heating. Silica column chromatography was performed using Merck Geduran® 60 Å (40-62 µm) or using a Biotage Isolera™ Prime auto column (10-100 g SNAP ultra-cartridges). 1 H NMR (400 MHz), 13 C NMR (101 MHz) and 31 P NMR (162 MHz) were recorded using a Bruker DPX 400 (AVIIIHD 400) or Bruker AVII 500 spectrometer ( 1 H-500 MHz, 13 C-126 MHz) and referenced to an appropriate deuterated solvent. Assignment was aided by DEPT-135, COSY, HSQC-DEPT and HMBC spectra. Data was then processed using MestreNova software. Low resolution mass spectrometry (LRMS) using electrospray ionisation positive (ESI+) and negative (ESI-) modes was recorded on a Waters ZMD quadrupole mass spectrometer in HPLC grade MeOH/MeCN. High resolution mass spectrometry (HRMS) using electrospray ionisation was recorded on a Bruker APEX III FT-ICR mass spectrometer. Oligonucleotide mass spectrometry was recorded on a UPLC-MS Waters XEVO G2-QTOF (ESI-) using an ACQUITY UPLC oligonucleotide BEH C18 column, 130 Å (1.7 µm, 2.1 mm × 50 mm). Data was then deconvoluted using MassLynx v4. 
Synthesis of CBM 1 dinucleotide phosphoramidites

3′-O-Carbonylimidazole-5′-O-dimethoxytrityl-LNA-thymidine (4)
Compound 3 (1.11 g, 1.94 mmol) and 1,1′-carbonyldiimidazole (0.630 g, 3.88 mmol) were separately co-evaporated in dry THF (3 × 5.00 mL), and each re-dissolved in dry THF (20.0 mL). The solution of compound 3 was then added dropwise to a solution of CDI over 1 h and stirred for further 20 h at rt. The solvent was removed under reduced pressure and re-dissolved in EtOAc (100 mL), washed with 5% KH 2 PO 4 (2 × 100 mL) and dried over Na 2 SO 4 5′-Azido-3′-benzyl-5′-deoxy-LNA-thymidine (7) 1 To a solution of compound 6 (1.00 g, 2.28 mmol) in DMF (7.00 mL) was added sodium azide (1.01 g, 15.5 mmol) and stirred at 65 °C for 20 h. The solvent was removed under reduced pressure, resuspended in EtOAc (70.0 mL) and filtered over silica. Evaporation of the solvent gave an oil which was purified by silica column chromatography (Petroleum ether:EtOAc, 3:7 to 0:10) C NMR (101 MHz, CDCl 3 ) δ 163.7 (C-4), 149.8 (C-2), 136.7 (C-Ar), 134.4 (C-6), 128.7 (C-Ar), 128.5 (C-Ar), 128.0 (C-Ar), 110.8 (C-5), 87.8 (C-1′), 86.9 (C-4′), 76.8 (C-2′), 76.4 (C-3′), 72.5 (C-7), 72.5 (C-8), 47.5 (C-5′), 12. Amine 8 (282 mg, 1.05 mmol) and carbonate 2 (750 mg, 1.06 mmol) were separately co-evaporated with dry pyridine (3 × 5.00 mL) and each dissolved in dry pyridine (5.00 mL). The solution of carbonate 2 was added dropwise to amine 8 and stirred at 80 °C for 16 h. The reaction was concentrated under reduced pressure and purified by silica column chromatography (EtOAc:MeOH, 49:1 to 25:1 + 1% Et 3 N). This gave a white solid which was re-dissolved in CHCl 3 : 
To a solution of dimer 10 (480 mg, 0.570 mmol) in dry, degassed CH 2 Cl 2 (5.00 mL), was added degassed DIPEA (250 μL, 1.44 mmol) followed by chloro(diisopropylamino)-β-cyanoethoxyphosphine (180 μL, 0.810 mmol) dropwise over 10 min. After 1 h at rt, a second portion of chloro(diisopropylamino)-β-cyanoethoxyphosphine (120 μL, 0.540 mmol) and DIPEA (120 μL, 0.690 mmol) was added and stirred for another 1 h. The reaction mixture was diluted with dry CH 2 Cl 2 (10.0 mL) and washed with sat. aq KCl (10.0 mL). The organic layer was dried over Na 2 SO 4 and the solvents were evaporated under reduced pressure. The solid was re-dissolved in dry, degassed CH 2 Cl 2 (2.50 mL) and precipitated by addition of degassed hexane (250 mL). The suspension was cooled to 4 °C and the supernatant was decanted. The remaining slurry was dried under reduced pressure to give a white solid. Purification by column chromatography (Hexane: EtOAc, 1:10 + 1% pyridine) gave building block 14 (338 mg, 0.320 mmol, 57%) as a white solid. To a solution of dimer 12 (334 mg, 0.380 mmol) in dry degassed CH 2 Cl 2 (3.50 mL) was added degassed DIPEA (165 μL, 950 μmol). Chloro(diisopropylamino)-β-cyanoethoxyphosphine (120 μL, 540 μmol) was added dropwise over 10 min and the reaction was stirred at rt for 1 h. After 1 h, a second portion of chloro(diisopropylamino)-β-cyanoethoxyphosphine (100 μL, 450 μmol) was added and stirred for another 1 h. The reaction mixture was diluted with dry degassed CH 2 Cl 2 (10.0 mL) and washed with sat. aq KCl (10.0 mL) under an argon atmosphere. The organic layer was dried over Na 2 SO 4 and the solvents were evaporated under reduced pressure. The solid was re-dissolved in dry degassed CH 2 Cl 2 (2.50 mL) and precipitated by addition of hexane (150 mL). The supernatant was decanted and the solid dried under reduced pressure. The precipitation was repeated followed by silica column chromatography To a solution of dimer 26 (490 mg, 580 μmol) in dry degassed CH 2 Cl 2 (5.00 mL) was added dry degassed DIPEA (254 μL, 1.50 mmol) followed by chloro(diisopropylamino)-β-cyanoethoxyphosphine (196 μL, 880 μmol) and stirred at rt under argon for 1 h. The reaction was diluted with degassed CH 2 Cl 2 (5.00 mL), washed with sat. aq KCl (5.00 mL) and dried over Na 2 SO 4 . The organic layer was concentrated under reduced pressure and purified by silica column chromatography (degassed EtOAc) to give phosphoramidite 27 (260 mg, 250 μmol 43%). R f 0.56 (EtOAc); 
Synthesis of CBM 2 dinucleotide phosphoramidites
3′-O-(Benzyl)-5′-O-(4-nitrophenyl formate)-LNA-thymidine (21)
Synthesis and purification of oligonucleotides Synthesis of DNA oligonucleotides
Standard phosphoramidites, solid supports and reagents were purchased from Link Technologies and Applied Biosystems. LNA phosphoramidites were obtained from Exiqon. Automated solid phase synthesis of oligonucleotides (trityl off) was performed on an Applied Biosystems 394 synthesiser. Synthesis was performed on 1.0 µmole scale involving cycles of acid catalysed detritylation, coupling, capping, and iodine oxidation. Standard DNA phosphoramidites were coupled for 60 s while extended coupling time of 10 min was used for LNA phosphoramidites. Coupling efficiencies and overall synthesis yields were determined by the inbuilt automated trityl cation conductivity monitoring facility and were ≥98.0% in all cases. The oligonucleotides were then cleaved from the solid support and protecting groups from the nucleobase and backbone were removed by exposure to conc. aq ammonium hydroxide for 60 min at room temperature, followed by heating in a sealed tube for 5 h at 55 °C.
Synthesis of RNA oligonucleotides
2′-O-TBDMS protected RNA phosphoramidite monomers with t-butylphenoxyacetyl protection of the A, G and C nucleobases were used to assemble RNA oligonucleotides. Benzylthiotetrazole (BTT) was used as the coupling agent, t-butylphenoxyacetic anhydride as the capping agent and 0.1 M iodine as the oxidizing agent (Sigma-Aldrich). Coupling time of 10 min was used and coupling efficiencies of >97% were obtained. Cleavage of oligonucleotides from the solid support and protecting groups from the nucleobase and backbone were removed by exposure to concentrated aqueous ammonia/ethanol (3/1 v/v) for 2 h at room temperature followed by heating in a sealed tube for 2 h at 55°C.
Removal of 2′-O-TBDMS protecting groups on RNA oligonucleotides
Oligonucleotides were concentrated under reduced pressure until formation of a white turbidity and freeze dried overnight. The residue was then re-dissolved in DMSO (300 μL) and triethylamine trihydrofluoride (300 μL) was added followed by incubation at 65 °C for 2.5 h. Sodium acetate (3 M, 50 μL) and butanol (3 mL) were added and the samples were stored at -80 °C for a minimum of 1 h. After thawing the suspension was pelleted under centrifuge (13,000 rpm, 4 °C, 10 min) and the supernatant decanted. The precipitate was then washed with ethanol (2 × 750 μL) then dried under vacuum.
Purification of oligonucleotides
Oligonucleotides were purified using high performace liquid chromatography (HPLC) performed on a Gilson 118 UV detector, with 306 pumps, 805 manometric module, and 811c dynamic mixer, equipped with a Phenomenex Luna 10 μm C8 column (100 Å pore; 10 × 250 mm). A gradient of acetonitrile in 0.1 M TEAB buffer (from 10:90 to 40:60 acetonitrile:TEAB ) was used to elute the ONs at rt over 20 mins at a flow rate of 4 mL/min. Elution was monitored by UV absorbance at 285-300 nm. Collected fractions were freeze-dried overnight and re-suspended in 1 mL deionised water. 
Biophysical studies and assays Ultraviolet melting studies UV DNA melting curves were recorded in a Cary 4000 Scan UV-Visible Spectrophotometer using 3 µM of each oligonucleotide in a 10 mM phosphate buffer containing 200 mM NaCl at pH 7.0. Samples were annealed by heating to 85 °C (10 °C/min) and then slowly cooling to 20 °C (1 °C/min). As these six successive cycles (heating and cooling) were performed at a gradient of 1 °C/min, the change in UV absorbance at 260 nm was recorded. The melting temperature was calculated from the first derivative of the melting curve using in built software.
Additional UV-data 
Circular dichroism studies
A solution of 3 µM sample oligonucleotide and complementary sequence was added to 10 mM phosphate buffer with 200 mM NaCl (pH 7.0). Sample were incubated for 2 mins at 85 °C and cooled to rt. Circular dichroisms was performed on a Chirscan Plus spectrometer using a quartz cuvette (L = 10 mm). Scans were taken at 20 °C from 200-340 nm with 0.5 a step and 1.0 s time point intervals. The average of four scan were taken and smoothed to 20 points using a third order polynomial (OriginPro 2017). The spectra were then baseline corrected to the θ-value at 340 nm. 
Snake venom assay
5 nmol of oligonucleotide was dissolved in 100 μL of buffer (50 mM Tris-HCl, 10 mM MgCl 2 , pH 9.0). 20 μL of sample was removed (t = 0 control) and 2 μL of snake venom phosphodiesterase 1 from C. adamanteus (Sigma-Aldrich, cat P3243, 0.45 units, dissolved in 7 mL H 2 O) was added to the remaining volume. The reaction was incubated at 37 °C and 20 μL aliquots were removed at set times, mixed with formamide (v/v) and stored at -80 °C. Samples were analysed by 20% denatured polyacrylamide gel electrophoresis (400 V) and viewed under short wave UV-light. 
Foetal bovine serum (FBS) assay
27 NMR spectra
